Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.

Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.

Détails bibliographiques
Auteurs principaux: Croucher, P, Hijzen, A, Shipman, C, Perry, M, Lippitt, J, Green, J, Van Camp, B, Vanderkerken, K
Format: Journal article
Publié: 2001
Description
Résumé:

Documents similaires